moxifloxacin has been researched along with sch 527123 in 1 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (sch 527123) | Trials (sch 527123) | Recent Studies (post-2010) (sch 527123) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 18 | 0 | 12 |
Protein | Taxonomy | moxifloxacin (IC50) | sch 527123 (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.1021 | |
C-X-C chemokine receptor type 2 | Homo sapiens (human) | 0.1183 | |
C-X-C chemokine receptor type 2 | Mus musculus (house mouse) | 0.0081 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for moxifloxacin and sch 527123
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |